Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 3Phase 3 1Phase 1/2 1Phase 1 1

Status

Completed 14Terminated 4Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 41Carcinoma, Non-Small-Cell Lung 28Colorectal Neoplasms 16Neoplasms 13Nasopharyngeal Carcinoma 11Lung Neoplasms 10Leukemia, Myeloid, Acute 10Carcinoma, Hepatocellular 10Stomach Neoplasms 9Prostatic Neoplasms 9Ovarian Neoplasms 8Multiple Myeloma 8Squamous Cell Carcinoma of Head and Neck 7Small Cell Lung Carcinoma 7Rectal Neoplasms 7Esophageal Neoplasms 7Triple Negative Breast Neoplasms 6Pancreatic Neoplasms 6Non-Muscle Invasive Bladder Neoplasms 6Uterine Cervical Neoplasms 5Recurrence 5Neoplasm Metastasis 5Glioblastoma 5Colonic Neoplasms 5Brain Neoplasms 5Adenocarcinoma 5Urinary Bladder Neoplasms 4Polycystic Ovary Syndrome 4Lymphoma, Follicular 4Fallopian Tube Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Cachexia × Clear all
NCT07356037 2026-01-21

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
68 enrolled
Gastrointestinal

Cachexia, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡